PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.\', \'School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.\', \'KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, 3000 Leuven, Belgium.\', \'Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.\', \'Abbvie Bioresearch Center, Worcester, MA, USA.\', \'Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.\', \'CEA, Université Paris Sud 11, INSERM U1184, Center for Immunology of Viral Infections and Autoimmune Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses, France.\', \'VRI, Université Paris-Est Créteil, Faculté de Médicine, INSERM U955, 94010 Créteil, France; INSERM U955, Equipe 16, Créteil, France; AP-HP, Ho^pital Henri-Mondor Albert-Chenevier, Service d\'Immunologie Clinique et Maladies Infectieuses, Créteil, France.\', \'School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. Electronic address: didier.trono@epfl.ch.\', \'Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; VRI, Université Paris-Est Créteil, Faculté de Médicine, INSERM U955, 94010 Créteil, France; Swiss Vaccine Research Institute, Lausanne University Hospital and University of Lausanne, Switzerland. Electronic address: giuseppe.pantaleo@chuv.ch.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2211-1247(21)01278-X10.1016/j.celrep.2021.109814
?:doi
?:hasPublicationType
?:journal
  • Cell reports
is ?:pmid of
?:pmid
?:pmid
  • 34599871
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.552
?:rankingScore_hIndex
  • 92
?:title
  • A highly potent antibody effective against SARS-CoV-2 variants of concern.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all